Advanced Parenteral drug delivery Market Report

Global Advanced Parenteral drug delivery Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 24, 2022
  • PAGES：172
  • REPORT CODE：GMM767098
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Advanced Parenteral drug delivery market report explains the definition, types, applications, major countries, and major players of the Advanced Parenteral drug delivery market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Abbott Laboratories

    • AstraZeneca

    • Pfizer

    • Bristol-Myers Squibb

    • AptarGroup

    • Novartis

    • Hoffmann-La Roche

    • Boston Scientific

    • Baxter

    • GlaxoSmithKline

    • Amgen

    • Dickinson

    • Becton

    By Type:

    • Prefillable Syringes

    • Injectors Cartridges

    • Hypodermic Syringes

    • IV Catheters

    • Other Parenteral Delivery Devices

    By End-User:

    • Government Hospitals

    • Private Hospitals and Clinics

    • Healthcare Organizations

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Advanced Parenteral drug delivery Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Advanced Parenteral drug delivery Outlook to 2028- Original Forecasts

    • 2.2 Advanced Parenteral drug delivery Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Advanced Parenteral drug delivery Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Advanced Parenteral drug delivery Market- Recent Developments

    • 6.1 Advanced Parenteral drug delivery Market News and Developments

    • 6.2 Advanced Parenteral drug delivery Market Deals Landscape

    7 Advanced Parenteral drug delivery Raw Materials and Cost Structure Analysis

    • 7.1 Advanced Parenteral drug delivery Key Raw Materials

    • 7.2 Advanced Parenteral drug delivery Price Trend of Key Raw Materials

    • 7.3 Advanced Parenteral drug delivery Key Suppliers of Raw Materials

    • 7.4 Advanced Parenteral drug delivery Market Concentration Rate of Raw Materials

    • 7.5 Advanced Parenteral drug delivery Cost Structure Analysis

      • 7.5.1 Advanced Parenteral drug delivery Raw Materials Analysis

      • 7.5.2 Advanced Parenteral drug delivery Labor Cost Analysis

      • 7.5.3 Advanced Parenteral drug delivery Manufacturing Expenses Analysis

    8 Global Advanced Parenteral drug delivery Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Advanced Parenteral drug delivery Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Advanced Parenteral drug delivery Export by Region (Top 10 Countries) (2017-2028)

    9 Global Advanced Parenteral drug delivery Market Outlook by Types and Applications to 2022

    • 9.1 Global Advanced Parenteral drug delivery Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Prefillable Syringes Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Injectors Cartridges Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Hypodermic Syringes Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global IV Catheters Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Parenteral Delivery Devices Consumption and Growth Rate (2017-2022)

    • 9.2 Global Advanced Parenteral drug delivery Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Government Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Private Hospitals and Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Healthcare Organizations Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Advanced Parenteral drug delivery Market Analysis and Outlook till 2022

    • 10.1 Global Advanced Parenteral drug delivery Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.2.2 Canada Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.2.3 Mexico Advanced Parenteral drug delivery Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.3.2 UK Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.3.3 Spain Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.3.4 Belgium Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.3.5 France Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.3.6 Italy Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.3.7 Denmark Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.3.8 Finland Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.3.9 Norway Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.3.10 Sweden Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.3.11 Poland Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.3.12 Russia Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.3.13 Turkey Advanced Parenteral drug delivery Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.4.2 Japan Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.4.3 India Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.4.4 South Korea Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.4.5 Pakistan Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.4.6 Bangladesh Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.4.7 Indonesia Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.4.8 Thailand Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.4.9 Singapore Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.4.10 Malaysia Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.4.11 Philippines Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.4.12 Vietnam Advanced Parenteral drug delivery Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.5.2 Colombia Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.5.3 Chile Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.5.4 Argentina Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.5.5 Venezuela Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.5.6 Peru Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.5.7 Puerto Rico Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.5.8 Ecuador Advanced Parenteral drug delivery Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.6.2 Kuwait Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.6.3 Oman Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.6.4 Qatar Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Advanced Parenteral drug delivery Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.7.2 South Africa Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.7.3 Egypt Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.7.4 Algeria Advanced Parenteral drug delivery Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Advanced Parenteral drug delivery Consumption (2017-2022)

      • 10.8.2 New Zealand Advanced Parenteral drug delivery Consumption (2017-2022)

    11 Global Advanced Parenteral drug delivery Competitive Analysis

    • 11.1 Abbott Laboratories

      • 11.1.1 Abbott Laboratories Company Details

      • 11.1.2 Abbott Laboratories Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Abbott Laboratories Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.1.4 Abbott Laboratories Advanced Parenteral drug delivery Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 AstraZeneca

      • 11.2.1 AstraZeneca Company Details

      • 11.2.2 AstraZeneca Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 AstraZeneca Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.2.4 AstraZeneca Advanced Parenteral drug delivery Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Pfizer

      • 11.3.1 Pfizer Company Details

      • 11.3.2 Pfizer Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Pfizer Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.3.4 Pfizer Advanced Parenteral drug delivery Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Bristol-Myers Squibb

      • 11.4.1 Bristol-Myers Squibb Company Details

      • 11.4.2 Bristol-Myers Squibb Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Bristol-Myers Squibb Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.4.4 Bristol-Myers Squibb Advanced Parenteral drug delivery Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 AptarGroup

      • 11.5.1 AptarGroup Company Details

      • 11.5.2 AptarGroup Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 AptarGroup Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.5.4 AptarGroup Advanced Parenteral drug delivery Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Novartis

      • 11.6.1 Novartis Company Details

      • 11.6.2 Novartis Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Novartis Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.6.4 Novartis Advanced Parenteral drug delivery Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Hoffmann-La Roche

      • 11.7.1 Hoffmann-La Roche Company Details

      • 11.7.2 Hoffmann-La Roche Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Hoffmann-La Roche Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.7.4 Hoffmann-La Roche Advanced Parenteral drug delivery Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Boston Scientific

      • 11.8.1 Boston Scientific Company Details

      • 11.8.2 Boston Scientific Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Boston Scientific Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.8.4 Boston Scientific Advanced Parenteral drug delivery Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Baxter

      • 11.9.1 Baxter Company Details

      • 11.9.2 Baxter Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Baxter Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.9.4 Baxter Advanced Parenteral drug delivery Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 GlaxoSmithKline

      • 11.10.1 GlaxoSmithKline Company Details

      • 11.10.2 GlaxoSmithKline Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 GlaxoSmithKline Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.10.4 GlaxoSmithKline Advanced Parenteral drug delivery Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Amgen

      • 11.11.1 Amgen Company Details

      • 11.11.2 Amgen Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Amgen Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.11.4 Amgen Advanced Parenteral drug delivery Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Dickinson

      • 11.12.1 Dickinson Company Details

      • 11.12.2 Dickinson Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Dickinson Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.12.4 Dickinson Advanced Parenteral drug delivery Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Becton

      • 11.13.1 Becton Company Details

      • 11.13.2 Becton Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Becton Advanced Parenteral drug delivery Main Business and Markets Served

      • 11.13.4 Becton Advanced Parenteral drug delivery Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Advanced Parenteral drug delivery Market Outlook by Types and Applications to 2028

    • 12.1 Global Advanced Parenteral drug delivery Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Prefillable Syringes Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Injectors Cartridges Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Hypodermic Syringes Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global IV Catheters Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Other Parenteral Delivery Devices Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Advanced Parenteral drug delivery Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Government Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Private Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Healthcare Organizations Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Advanced Parenteral drug delivery Market Analysis and Outlook to 2028

    • 13.1 Global Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.2.2 Canada Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.3.2 UK Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.3.3 Spain Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.3.5 France Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.3.6 Italy Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.3.8 Finland Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.3.9 Norway Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.3.11 Poland Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.3.12 Russia Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.4.2 Japan Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.4.3 India Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.5.3 Chile Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.5.6 Peru Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.6.3 Oman Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Advanced Parenteral drug delivery Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Advanced Parenteral drug delivery

    • Figure of Advanced Parenteral drug delivery Picture

    • Table Global Advanced Parenteral drug delivery Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Advanced Parenteral drug delivery Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Prefillable Syringes Consumption and Growth Rate (2017-2022)

    • Figure Global Injectors Cartridges Consumption and Growth Rate (2017-2022)

    • Figure Global Hypodermic Syringes Consumption and Growth Rate (2017-2022)

    • Figure Global IV Catheters Consumption and Growth Rate (2017-2022)

    • Figure Global Other Parenteral Delivery Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Government Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Private Hospitals and Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Healthcare Organizations Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Advanced Parenteral drug delivery Consumption by Country (2017-2022)

    • Table North America Advanced Parenteral drug delivery Consumption by Country (2017-2022)

    • Figure United States Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Canada Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Mexico Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Table Europe Advanced Parenteral drug delivery Consumption by Country (2017-2022)

    • Figure Germany Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure UK Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Spain Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Belgium Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure France Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Italy Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Denmark Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Finland Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Norway Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Sweden Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Poland Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Russia Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Turkey Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Table APAC Advanced Parenteral drug delivery Consumption by Country (2017-2022)

    • Figure China Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Japan Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure India Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure South Korea Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Thailand Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Singapore Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Philippines Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Table South America Advanced Parenteral drug delivery Consumption by Country (2017-2022)

    • Figure Brazil Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Colombia Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Chile Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Argentina Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Peru Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Table GCC Advanced Parenteral drug delivery Consumption by Country (2017-2022)

    • Figure Bahrain Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Oman Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Qatar Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Table Africa Advanced Parenteral drug delivery Consumption by Country (2017-2022)

    • Figure Nigeria Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure South Africa Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Egypt Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure Algeria Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Table Oceania Advanced Parenteral drug delivery Consumption by Country (2017-2022)

    • Figure Australia Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Advanced Parenteral drug delivery Consumption and Growth Rate (2017-2022)

    • Table Abbott Laboratories Company Details

    • Table Abbott Laboratories Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Advanced Parenteral drug delivery Main Business and Markets Served

    • Table Abbott Laboratories Advanced Parenteral drug delivery Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Advanced Parenteral drug delivery Main Business and Markets Served

    • Table AstraZeneca Advanced Parenteral drug delivery Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Advanced Parenteral drug delivery Main Business and Markets Served

    • Table Pfizer Advanced Parenteral drug delivery Product Portfolio

    • Table Bristol-Myers Squibb Company Details

    • Table Bristol-Myers Squibb Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Advanced Parenteral drug delivery Main Business and Markets Served

    • Table Bristol-Myers Squibb Advanced Parenteral drug delivery Product Portfolio

    • Table AptarGroup Company Details

    • Table AptarGroup Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table AptarGroup Advanced Parenteral drug delivery Main Business and Markets Served

    • Table AptarGroup Advanced Parenteral drug delivery Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Advanced Parenteral drug delivery Main Business and Markets Served

    • Table Novartis Advanced Parenteral drug delivery Product Portfolio

    • Table Hoffmann-La Roche Company Details

    • Table Hoffmann-La Roche Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hoffmann-La Roche Advanced Parenteral drug delivery Main Business and Markets Served

    • Table Hoffmann-La Roche Advanced Parenteral drug delivery Product Portfolio

    • Table Boston Scientific Company Details

    • Table Boston Scientific Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Scientific Advanced Parenteral drug delivery Main Business and Markets Served

    • Table Boston Scientific Advanced Parenteral drug delivery Product Portfolio

    • Table Baxter Company Details

    • Table Baxter Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Advanced Parenteral drug delivery Main Business and Markets Served

    • Table Baxter Advanced Parenteral drug delivery Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Advanced Parenteral drug delivery Main Business and Markets Served

    • Table GlaxoSmithKline Advanced Parenteral drug delivery Product Portfolio

    • Table Amgen Company Details

    • Table Amgen Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Advanced Parenteral drug delivery Main Business and Markets Served

    • Table Amgen Advanced Parenteral drug delivery Product Portfolio

    • Table Dickinson Company Details

    • Table Dickinson Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dickinson Advanced Parenteral drug delivery Main Business and Markets Served

    • Table Dickinson Advanced Parenteral drug delivery Product Portfolio

    • Table Becton Company Details

    • Table Becton Advanced Parenteral drug delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Advanced Parenteral drug delivery Main Business and Markets Served

    • Table Becton Advanced Parenteral drug delivery Product Portfolio

    • Figure Global Prefillable Syringes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injectors Cartridges Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hypodermic Syringes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IV Catheters Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Parenteral Delivery Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Government Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Private Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Healthcare Organizations Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Advanced Parenteral drug delivery Consumption Forecast by Country (2022-2028)

    • Table North America Advanced Parenteral drug delivery Consumption Forecast by Country (2022-2028)

    • Figure United States Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Advanced Parenteral drug delivery Consumption Forecast by Country (2022-2028)

    • Figure Germany Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Advanced Parenteral drug delivery Consumption Forecast by Country (2022-2028)

    • Figure China Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Advanced Parenteral drug delivery Consumption Forecast by Country (2022-2028)

    • Figure Brazil Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Advanced Parenteral drug delivery Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Advanced Parenteral drug delivery Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Advanced Parenteral drug delivery Consumption Forecast by Country (2022-2028)

    • Figure Australia Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Advanced Parenteral drug delivery Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US